Pharmaceutical Business review

PGI to invest in expanding new production plant in China

The investment increases the plant’s capacity of manufacturing advanced chemical bond products for hygiene applications to fulfill the increasing needs of customers in the region.

The new facility will leverage from the company’s current and new production technologies and is expected to be completed by the first half of 2016.

PGI’s investment will be supported by its key partner, The Nanhai District People’s Government in the region.